EDC for Hybrid Clinical Trials

EDC for hybrid clinical trials: site and remote workflows, consent, and ePRO in one platform with 21 CFR Part 11–aligned controls.

21 CFR Part 11 aligned · HIPAA-aligned security · No credit card required

Supporting site and remote visits in one study record

Hybrid trials are operationally different from fully decentralized trials because participants may move between site visits and remote touchpoints throughout the same protocol. Screening may happen on site, consent may be remote or in person, follow-up may alternate between clinic assessments and ePRO, and safety checks may happen by phone. The EDC needs to make those mode changes visible without splitting the participant record across systems. Capture supports hybrid workflows by keeping site-entered CRFs, eConsent, ePRO, safety forms, queries, and exports in one platform. A visit can be configured around the data needed for that touchpoint, whether it is collected during a clinic visit or remotely. Site staff can document what happened during in-person assessments, while participants can complete protocol-defined ePRO instruments between visits. The participant timeline remains easier to follow because consent, CRFs, patient-reported data, and safety records share one audit model. That matters when a study starts site-heavy and becomes more remote, or when a protocol allows remote follow-up for participants who cannot return to the clinic. A single record helps the team maintain continuity even when the operating model changes.

  • Site CRFs, remote ePRO, eConsent, safety records, queries, and exports in one platform
  • Visit structures that can support clinic visits, phone follow-up, and remote assessments
  • One participant timeline across in-person and remote touchpoints
  • Shared audit trails for site-entered and participant-reported data

Avoiding duplicate workflows for hybrid operations

A common hybrid-trial problem is duplicate work. Sites enter visit data in the EDC, participants complete remote forms in another system, consent is stored somewhere else, and the sponsor keeps a spreadsheet to track which participants are remote, on site, or overdue. This creates avoidable reconciliation work and makes it harder to know which dataset is authoritative. Capture reduces that operational burden by giving hybrid teams one governed place for the core study data. eConsent records can be connected to enrollment. ePRO can capture patient-reported outcomes between visits. CRFs can document site assessments, remote calls, protocol deviations, and safety follow-up. Query workflows let monitors and data managers resolve issues without maintaining side-channel trackers. Hybrid studies still may use external services for labs, telemedicine, imaging, devices, or home nursing. The point is not to collapse every vendor into one tool; it is to keep the clinical dataset organized so the study team does not have to reconstruct the participant journey from disconnected sources at the end of the trial.

  • One governed clinical dataset for site and remote data capture
  • Less reconciliation between eConsent, EDC, ePRO, and tracking spreadsheets
  • Query workflows for missing or inconsistent hybrid-visit records
  • A clear clinical data layer alongside labs, devices, telemedicine, or home-visit vendors

Reviewing mixed-mode data before database lock

Hybrid trials can introduce review questions that do not appear in simple site-only studies. Was the required assessment completed remotely or in person? Was the participant on the right consent version? Did the ePRO window align with the related clinic visit? Was a missed remote assessment handled as a deviation, a query, or a rescheduled visit? These details affect analysis and inspection readiness. Capture helps reviewers answer those questions from the participant record. Role-based access allows coordinators, investigators, monitors, and sponsor reviewers to work from the same system. Audit trails show changes to CRFs, ePRO records, consent records, and safety forms. Structured exports keep the data organized for analysis after lock. For hybrid teams, the value is practical: the study can adapt to real-world participant needs without making the dataset harder to govern. Sites get a familiar EDC workflow, participants can complete remote assessments where the protocol allows, and sponsors retain one audit trail across both modes.

  • Review of visit mode, assessment completion, consent version, and ePRO timing
  • Role-based monitor and sponsor access for mixed site and remote workflows
  • Audit trails across CRFs, eConsent, ePRO, safety records, and queries
  • Structured exports that preserve site and remote assessment context

Overview

EDC for Hybrid Clinical Trials

Hybrid clinical trials combine on-site visits with remote consent, telemedicine, or patient-reported data capture. Your EDC must support both site-based and remote workflows in one system so consent, CRFs, and ePRO share one audit trail. Capture provides EDC, eConsent, ePRO, and safety in one platform with 21 CFR Part 11–aligned controls and HIPAA-aligned infrastructure, so hybrid trial teams can run end-to-end workflows across site and remote touchpoints without stitching together multiple vendors.

Why hybrid trials need the right EDC

Hybrid trials require one system that supports both site and remote touchpoints—consent (on-site or remote), CRFs, and ePRO—with one audit trail. Legacy setups often combine separate eConsent, EDC, and ePRO tools, complicating hybrid workflows and monitoring. Capture is built for end-to-end workflow: electronic consent, visit-based and ePRO data capture, and optional remote touchpoints in one platform with 21 CFR Part 11–aligned controls and HIPAA-aligned security.

Common hybrid trial workflow

  • Protocol and consent; on-site or remote consent and e-signature
  • Site and optional remote enrollment; patient onboarding
  • Site visits and optional remote/ePRO data capture
  • Safety and AE capture; data review and queries
  • Database lock and export for analysis and regulatory use

Traditional tool pain points

  • Separate eConsent, EDC, and ePRO systems; no single audit trail
  • Complex integration for site and remote workflows
  • High cost for hybrid or multi-vendor stacks
  • Limited support for mixed site and remote touchpoints

How Capture supports hybrid trials

  • Unified EDC, eConsent, and ePRO; one platform for site and remote data
  • End-to-end workflow; one audit trail for all touchpoints
  • 21 CFR Part 11–aligned controls and HIPAA-aligned security
  • Export for analysis and regulatory use; documentation for validation (Enterprise)

FAQ

Questions we hear a lot

Is Capture suitable for hybrid clinical trials?
Yes. Capture supports hybrid trials with eConsent, EDC, and ePRO in one platform. You get one audit trail for site and remote data with 21 CFR Part 11–aligned controls.
How do site and remote workflows work together?
Capture includes electronic consent and ePRO in the same platform as EDC. Site and remote data are captured with the same audit trail and security controls, so hybrid workflows are traceable end to end.
What about compliance?
Capture is designed with 21 CFR Part 11–aligned controls and HIPAA-aligned security. We provide documentation to support sponsor validation when required (Enterprise).

Ready to see Capture in action?

Explore the platform with a free sandbox. No sales call required.

Explore platform